Treating hospitalized COVID-19 patients with anticoagulants–blood thinners that slow down clotting–may improve their chances of survival, researchers from the Mount Sinai COVID Informatics Center report.

The study, published in the May 6 issue of the Journal of the American College of Cardiology, could provide new insight on how to treat and manage coronavirus patients once they are admitted to the hospital.

The study found that hospitalized COVID-19 patients treated with anticoagulants had improved outcomes both in and out of the intensive care unit setting.

The research also showed that the difference in bleeding events among patients treated with and without anticoagulants was not significant.

The Mount Sinai researchers say their work outlines an important therapeutic pathway for COVID-19 patients.

Read More